| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-30 17:18 Tx date 2026-03-26 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-35,010.42
-4,938 vol $7.09 each |
9,724 | |
| Filed 2026-03-27 18:07 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$30,813
+4,891 vol $6.30 each |
13,768 | |
| Filed 2026-03-27 18:05 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$30,813
+4,891 vol $6.30 each |
13,768 | |
| Filed 2026-03-27 18:03 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$49,151
+7,668 vol $6.41 each |
14,662 | |
| Filed 2026-03-27 18:01 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-19,988.88
-4,502 vol $4.44 each |
8,877 | |
| Filed 2026-03-27 17:59 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-19,988.88
-4,502 vol $4.44 each |
8,877 | |
| Filed 2026-03-20 15:49 Tx date 2026-03-15 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,813
+456 vol $6.17 each |
6,994 | |
| Filed 2025-12-19 14:45 Tx date 2025-12-15 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,834
+470 vol $6.03 each |
6,538 | |
| Filed 2025-09-18 06:57 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,546
+868 vol $6.39 each |
6,068 | |
| Filed 2025-04-04 19:12 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$30,467
+4,938 vol $6.17 each |
5,200 | |
| Filed 2025-04-04 19:10 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-20,282.53
-3,893 vol $5.21 each |
13,379 | |
| Filed 2025-04-04 19:07 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-20,282.53
-3,893 vol $5.21 each |
13,379 | |
| Filed 2025-03-29 16:48 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$25,777
+4,151 vol $6.21 each |
17,272 | |
| Filed 2025-03-29 16:47 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$25,777
+4,151 vol $6.21 each |
17,272 | |
| Filed 2024-09-18 14:23 Tx date 2024-09-15 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,545
+262 vol $5.90 each |
262 | |
| Filed 2024-09-18 14:22 Tx date 2022-01-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-16 18:59 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$26,938
+4,726 vol $5.70 each |
13,121 | |
| Filed 2024-04-16 18:58 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$26,938
+4,726 vol $5.70 each |
13,121 | |
| Filed 2023-04-03 22:02 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$19,988
+4,502 vol $4.44 each |
8,395 | |
| Filed 2023-04-03 22:00 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$19,988
+4,502 vol $4.44 each |
8,395 |